Connor, Clark & Lunn Investment Management Ltd. Achillion Pharmaceuticals Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $20 Billion
  • Q4 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019
SELL
N/A
-68,034 Closed
0 $0
Q2 2019

Aug 07, 2019
SELL
N/A
-40,695 Reduced 37.43%
68,034 $182,000
Q1 2019

May 08, 2019
SELL
N/A
-47,125 Reduced 30.24%
108,729 $322,000
Q4 2018

Feb 12, 2019
BUY
N/A
33,097 Added 26.96%
155,854 $248,000
Q3 2018

Nov 13, 2018
BUY
N/A
20,450 Added 19.99%
122,757 $452,000
Q2 2018

Aug 02, 2018
BUY
N/A
3,115 Added 3.14%
102,307 $290,000
Q1 2018

May 14, 2018
BUY
N/A
2,700 Added 2.8%
99,192 $368,000
Q4 2017

Feb 09, 2018
SELL
N/A
-83,982 Reduced 46.53%
96,492 $278,000
Q3 2017

Nov 14, 2017
SELL
N/A
-162,075 Reduced 47.31%
180,474 $810,000
Q2 2017

Aug 14, 2017
BUY
N/A
342,549
342,549 $1.57 Million
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email